Share

October 29, 2013; 81 (18) Article

α-Synuclein in cutaneous autonomic nerves

Ningshan Wang, Christopher H. Gibbons, Jacob Lafo, Roy Freeman
First published October 2, 2013, DOI: https://doi.org/10.1212/WNL.0b013e3182a9f449
Full PDF
Citation
Permissions

Make Comment

See Comments

Downloads
1146

Share

Article Information

vol. 81 no. 18 1604-1610
DOI: 
https://doi.org/10.1212/WNL.0b013e3182a9f449
PubMed: 
24089386
Published By: 
Wolters Kluwer Health, Inc. on behalf of the American Academy of Neurology
Print ISSN: 
0028-3878
Online ISSN: 
1526-632X
History: 
  • Received April 5, 2013
  • Accepted in final form July 8, 2013
  • First Published October 2, 2013.

Article Versions

Copyright & Usage: 
© 2013 American Academy of Neurology

Author Disclosures

    1. Ningshan Wang, PhD*,
    2. Christopher H. Gibbons, MD, MMSc*,
    3. Jacob Lafo, BS and
    4. Roy Freeman, MD
  1. Ningshan Wang, PhD*,
    2. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  2. Christopher H. Gibbons, MD, MMSc*,
    3. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH NINDS K23NS020509

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. RJG Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  3. Jacob Lafo, BS and
    4. Scientific Advisory Boards:

    1. NONE

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. NONE

    Patents:

    1. NONE

    Publishing Royalties:

    1. NONE

    Employment, Commercial Entity:

    1. NONE

    Consultancies:

    1. NONE

    Speakers' Bureaus:

    1. NONE

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NONE

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. NONE

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  4. Roy Freeman, MD
    5. Scientific Advisory Boards:

    1. Abbott (2010-present) Alnylam (2012-present Bristol-Myers-Squibb (2010-present) Chelsea Pharmaceuticals (2007-present) Johnson and Johnson (2011-present) Pfizer (2001-present) Sanofi-Adventis (2012)

    Gifts:

    1. NONE

    Funding for Travel or Speaker Honoraria:

    1. NONE

    Editorial Boards:

    1. Autonomic Neuroscience - Basic and Clinical, Editor (2007-present) Clinical Autonomic Research, Editorial Board (1999-present) Clinical Journal of Pain, Assoc. Editor, 2009-2012 Clinical Journal of Pain, Editorial Board

    Patents:

    1. NONE

    Publishing Royalties:

    1. Royalties from UptoDate

    Employment, Commercial Entity:

    1. Received honorarium from educational activities sponsored by Pfizer and Eli Lilly

    Consultancies:

    1. Receive consulting fees from Eli Lilly (2004-2009), Pfizer (2000-2009), Solace (2006-2009), Glaxo Smith Kline (2008), UCB Pharma (2007-2009, Chelsea (2008)

    Speakers' Bureaus:

    1. Eli Lilly (2007-2009), Pfizer (2000-2009)

    Other Activities:

    1. NONE

    Clinical Procedures or Imaging Studies:

    1. NONE

    Research Support, Commercial Entities:

    1. NONE

    Research Support, Government Entities:

    1. NIH/NHLBI grant #R01HL109634 NIH/NINDS grant #U54 NS065736

    Research Support, Academic Entities:

    1. NONE

    Research Support, Foundations and Societies:

    1. Langer Family Foundation PI 2008-2009 Peripheral Neuropathy Foundation

    Stock/Stock Options/Board of Directors Compensation:

    1. NONE

    License Fee Payments, Technology or Inventions:

    1. NONE

    Royalty Payments, Technology or Inventions:

    1. NONE

    Stock/Stock Options, Research Sponsor:

    1. NONE

    Stock/Stock Options, Medical Equipment & Materials:

    1. NONE

    Legal Proceedings:

    1. NONE

  1. From the Department of Neurology, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, MA.
  1. Correspondence to Dr. Freeman: rfreeman{at}bidmc.harvard.edu
View Full Text

Article usage

Article usage: October 2013 to December 2022

AbstractFullPdfSource
Oct 2013176562165Highwire
Nov 201394019689Highwire
Dec 20133228735Highwire
Jan 20142027539Highwire
Feb 20141113521Highwire
Mar 20141111923Highwire
Apr 2014751817Highwire
May 2014972517Highwire
Jun 2014891415Highwire
Jul 2014791010Highwire
Aug 201455218Highwire
Sep 2014692013Highwire
Oct 2014661411Highwire
Nov 201456125Highwire
Dec 20142956Highwire
Jan 20153243Highwire
Jan 20150106pmc
Feb 20153894Highwire
Feb 201502012pmc
Mar 2015651010Highwire
Mar 201503018pmc
Apr 20153273Highwire
Apr 201501015pmc
May 201514711Highwire
May 201503417pmc
Jun 20151112Highwire
Jun 201501915pmc
Jul 20156375Highwire
Jul 201503123pmc
Aug 20156131Highwire
Aug 201501611pmc
Sep 20155441Highwire
Sep 201501815pmc
Oct 20151677Highwire
Oct 201501915pmc
Nov 20152944Highwire
Nov 20150179pmc
Dec 2015411611Highwire
Dec 201501511pmc
Jan 20164133Highwire
Jan 201602012pmc
Feb 20162544Highwire
Feb 201602518pmc
Mar 2016945Highwire
Mar 20160149pmc
Apr 201638114Highwire
Apr 201602211pmc
May 20161232Highwire
May 20160108pmc
Jun 20161811Highwire
Jun 201601811pmc
Jul 20162722Highwire
Jul 20160168pmc
Aug 20163612Highwire
Aug 2016092pmc
Sep 20163601Highwire
Sep 20160125pmc
Oct 20163002Highwire
Oct 20160166pmc
Nov 20163331Highwire
Nov 201602112pmc
Dec 20161610Highwire
Dec 20160212pmc
Jan 20172343Highwire
Jan 20170197pmc
Feb 20173311Highwire
Feb 2017096pmc
Mar 20172903Highwire
Mar 20170167pmc
Apr 20172100Highwire
Apr 20176119pmc
May 20171921Highwire
May 2017121721pmc
Jun 20171331Highwire
Jun 201731112pmc
Jul 2017921Highwire
Jul 201772324pmc
Aug 20172110Highwire
Aug 2017489pmc
Sep 20171501Highwire
Sep 201731820pmc
Oct 20172210Highwire
Oct 201731113pmc
Nov 20172511Highwire
Nov 201782123pmc
Dec 20172320Highwire
Jan 20181933Highwire
Feb 20184532Highwire
Mar 20184941Highwire
Apr 20185710Highwire
Apr 2018101920pmc
May 20188690Highwire
Jun 20187393Highwire
Jun 201862120pmc
Jul 20185411Highwire
Aug 20183310Highwire
Aug 2018101720pmc
Sep 20183333Highwire
Oct 20185224Highwire
Nov 20186011Highwire
Dec 20185110Highwire
Jan 20194031Highwire
Feb 20194522Highwire
Mar 20193010Highwire
Apr 20192500Highwire
May 20192210Highwire
Jun 20191610Highwire
Jul 20193140Highwire
Aug 20193083Highwire
Sep 20191400Highwire
Oct 20191701Highwire
Nov 20192522Highwire
Dec 20192754Highwire
Jan 20201600Highwire
Feb 20202921Highwire
Mar 20201820Highwire
Apr 20201631Highwire
May 20202610Highwire
Jun 20201722Highwire
Jul 20201312Highwire
Aug 20202119Highwire
Sep 20203841Highwire
Oct 20203613Highwire
Nov 20204722Highwire
Dec 20203292Highwire
Jan 20213642Highwire
Feb 20213420Highwire
Mar 20214574Highwire
Apr 20212431Highwire
May 20214372Highwire
Jun 20212774Highwire
Jul 20213931Highwire
Aug 20214022Highwire
Sep 20213071Highwire
Oct 20212820Highwire
Nov 20212454Highwire
Dec 20213322Highwire
Jan 20222711Highwire
Feb 20222422Highwire
Mar 20224500Highwire
Apr 20223020Highwire
May 20224631Highwire
Jun 20223720Highwire
Jul 20223733Highwire
Aug 20225820Highwire
Sep 20227374Highwire
Oct 20226340Highwire
Nov 20227421Highwire
Dec 20224700Highwire

Cited By...

Letters: Rapid online correspondence

No comments have been published for this article.
Comment

REQUIREMENTS

If you are uploading a letter concerning an article:
You must have updated your disclosures within six months: http://submit.neurology.org

Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.

If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.

Submission specifications:

  • Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
  • Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
  • Submit only on articles published within 6 months of issue date.
  • Do not be redundant. Read any comments already posted on the article prior to submission.
  • Submitted comments are subject to editing and editor review prior to posting.

More guidelines and information on Disputes & Debates

Compose Comment

More information about text formats

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.
Author Information
NOTE: The first author must also be the corresponding author of the comment.
First or given name, e.g. 'Peter'.
Your last, or family, name, e.g. 'MacMoody'.
Your email address, e.g. higgs-boson@gmail.com
Your role and/or occupation, e.g. 'Orthopedic Surgeon'.
Your organization or institution (if applicable), e.g. 'Royal Free Hospital'.
Publishing Agreement
NOTE: All authors, besides the first/corresponding author, must complete a separate Publishing Agreement Form and provide via email to the editorial office before comments can be posted.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

Vertical Tabs

You May Also be Interested in

Back to top

More Online

CME Course

Related Articles

Topics Discussed

Alert Me